Podcast by HCM Society
Tune into our bi-monthly podcast where we interview experts in the field to broaden the awareness of new HCM studies & advancements!
Listen to all the episodes wherever you enjoy podcasts: In the Thick of It (pod.link)
HCMS Podcast Episode 11.
How do you envision the role of gene therapy in shaping the future of cardiac care? In today’s episode, Dr. Sharlene Day engages in an enlightening conversation with Dr. Carolyn Ho, delving into the transformative world of gene therapy. Together, they navigate the complexities of gene therapy's fundamental concepts and potential applications in treating genetic cardiomyopathies and arrhythmia syndromes. Remember, understanding the potential of gene therapy is just the beginning. Collectively, we can pave the way for transformative advancements in treating genetic heart conditions by staying informed and engaged.
HCMS Podcast Episode 10.
Are the symptoms of nonobstructive hypertrophic cardiomyopathy (nHCM) holding patients back from living their fullest lives? Join Dr. Melissa Lyle and Dr. Michelle Kittleson as they unravel the mysteries of nHCM symptoms like congestion, angina, and exercise intolerance. How can we better manage these symptoms and pave the way for improved quality of life? Tune in as they explore innovative solutions, from advanced therapies to cutting-edge gene editing technologies like CRISPR, in the quest for better patient outcomes. Let's uncover the path to empowerment for nHCM patients together.
HCMS Podcast Episode 9.
Cardiologist Dr. Caroline Coats is talking with with Dr. James Moon, the CEO of Mycardium AI Ltd, and a distinguished Professor of Cardiology at University College London. Dr. Moon’s groundbreaking work in cardiac MRI, especially in hypertrophic cardiomyopathy, has changed the way professionals understand and diagnose heart conditions. Today, we’re delving into his wealth of knowledge and experience on imaging in HCM.
HCMS Podcast Episode 8.
Our topic of discussion today with Dr. Ayers and Dr. Owens is a critical one that impacts the world of cardiology and beyond cardiac myosin inhibitors. This cutting-edge area of research has the potential to revolutionize the way we approach cardiac diseases, and our experts are here to shed light on the latest developments, breakthroughs, and implications for patients and athletes alike.
HCMS Podcast Episode 7.
Dr. Robyn Bryde and Dr. Bradley Lander interview each presenting author of the selected abstracts to tell us more about their HCM research. These abstract presentations were selected to encore at the 2023 HCMS Scientific Sessions on October 6:
Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy - Presented by: Srekar Ravi, MD and Said Alsidawi, MD
Cumulative long-term efficacy and safety of mavacamten treatment in nonobstructive hypertrophic cardiomyopathy: updated interim analysis from the MAVERICK cohort of the MAVA-long-term extension (LTE) study up to 120 weeks - Presented by: Anjali Owens, MD
Classifying pathogenicity of TPM1 variants of unknown significance using in vitro and in silico approaches - Presented by: Stuart Campbell, MD
HCMS Podcast Episode 6.
n this episode, Cardiologist Dr. Robyn Bryde engages in an insightful conversation with Dr. Michael Emery. They delve into the crucial topic of exercise restrictions in HCM, exploring the art of crafting exercise prescriptions, counseling athletes and enthusiasts with HCM, and ensuring their safe participation in sports. Tune in for expert insights into this vital aspect of HCM management. Dr. Emery is an associate professor of medicine at the Cleveland Clinic Learner College of Medicine. He’s also the Co-Director of the sports cardiology center at Cleveland Clinic and has a background in exercise physiology.
HCMS Podcast Episode 5.
Host Dr. Eli Friedman chats with Dr. Ahmad Masri, of Oregan Health Sciences University Hypertrophic Cardiomyopathy Center. Dr. Friedman and Dr. Masri are good friends and former coworkers, and today they’re talking about finding treatment for patients with non-obstructive Hypertrophic Cardiomyopathy, specifically focusing on drugs on clinical trials and Cardiac Mitotrope Ninerafaxstat. Join us in this gripping episode as we dive into the world of non-obstructive Hypertrophic Cardiomyopathy with two experts who are on a mission to unravel its mysteries. Dr. Friedman and Dr. Masri share their insights on groundbreaking clinical trials and the potential game-changer, Cardiac Mitotrope Ninerafaxstats. Together, we'll explore the challenges, the breakthroughs, and how science is paving the way for a brighter future in cardiac care!
HCMS Podcast Episode 4.
Dr. Bradley Lander chats with Lisa Salberg, the founder of the HCMA, the Hypertrophic Cardiomyopathy Association. Since 1996, Lisa has been on a journey to educate, advocate, and support other patients based on her experience with HCM. By tuning in, you'll unwrap how HCM centers of excellence strive to provide holistic patient care, optimize treatment strategies, and incorporate mental health support, ultimately aiming to enhance the quality of life for those living with this complex genetic heart condition.
HCMS Podcast Episode 3.
Cardiologist Dr. Robyn Bryde interviews Dr. Matthew Martinez, the Director of Sports Cardiology and Hypertrophic Cardiomyopathy at Morristown Medical Center in New Jersey. Recorded from the Care of the Athletic Heart Conference, they discuss the effects of vigorous exercise on patients with hypertrophic cardiomyopathy (HCM). Historically, patients with HCM were advised to restrict exercise, but recent studies suggest that exercise may not worsen the condition. Dr. Martinez presents findings from a groundbreaking study involving 76 elite athletes with HCM, highlighting the importance of shared decision-making and expert consultation in developing exercise plans for these patients.
HCMS Podcast Episode 2.
Professor of medicine and director of the HCM Center at Westchester Medical Center in New York, Dr. Srihari Naidu, speaks with Haslam Family Endowed Chair in Cardiovascular Medicine, Dr. Milind Desai. Dr. Desai discusses his article published in the Journal of the American College of Cardiology, which looks at the long-term outcomes of septal reduction therapies in Medicare patients with obstructive hypertrophic cardiomyopathy.
HCMS Podcast Episode 1.
Learn more here in the first episode of In the Thick of It by HCMS. Special thanks to Dr. Rachel Lampert and the LIVE-HCM investigators for this important study!